CD38 and laryngotracheoesophageal cleft: By contrast, plasma from LC patients and supernatants from cultured LX2 cells failed to activate NK cells, and blockade of TGF-β could not reduce the CD38 and HLA-DR expression on NK cells in vitro (Supplemental Fig. 2).